Medplus Health Services Ltd.

NSE: MEDPLUS BSE: 543427 SECTOR: Pharmaceuticals & Drugs  104k   51   21

617.15
-2.25 (-0.36%)
NSE: 07 Oct 03:55 PM

Price Summary

Today's High

₹ 619.2

Today's Low

₹ 615

52 Week High

₹ 1343

52 Week Low

₹ 600

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

7362.95 Cr.

Enterprise Value

7355.51 Cr.

No. of Shares

11.93 Cr.

P/E

1319.82

P/B

6.68

Face Value

₹ 2

Div. Yield

0 %

Book Value (TTM)

₹  92.32

CASH

7.44 Cr.

DEBT

0 Cr.

Promoter Holding

40.43 %

EPS (TTM)

₹  0.47

Sales Growth

0

ROE

ROCE

Profit Growth

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year113.31%
3 Year148.29%
5 Year132.07%

Profit Growth

1 Year165.12%
3 Year60.98%
5 Year37.2%

ROE%

1 Year0.71%
3 Year-5.61%
5 Year-6.12%

ROCE %

1 Year1.01%
3 Year-3.01%
5 Year-2.54%

Debt/Equity

0

Price to Cash Flow

-355.59

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2022 40.43 59.47
Mar 2022 40.43 26.91
Dec 2021 40.43 26.91
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 148.285197254279% for the Past 3 years.
  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of 0 days.

 Limitations

  • Company has a poor ROE of -5.60655390475761% over the past 3 years.
  • Promoter pledging has increased from 40.43% to 59.47% in 1 quarter.
  • Company has a poor ROCE of -3.01382062993932% over the past 3 years
  • Company has negative cash flow from operations of -20.706.
  • The company has a low EBITDA margin of 0% over the past 5 years.
  • The company is trading at a high EV/EBITDA of 571.0977.
  • Promoter pledging is high as 59.47%.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2021 Mar 2022 Jun 2022
Net Sales 24.71 38.82 27.29
Total Expenditure 25.17 41.06 28.83
Operating Profit -0.46 -2.24 -1.54
Other Income 1.12 6.21 5.37
Interest 0.64 1.19 1.25
Depreciation 1.24 1.86 2.54
Exceptional Items 0 0 0
Profit Before Tax -1.21 0.92 0.04
Tax 0 0 0
Profit After Tax -1.21 0.92 0.04
Adjusted EPS (Rs) -0.1 0.08 0

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Net Sales 9.42 9.52 61.11 68.31 145.71
Total Expenditure 14.29 12.99 86.29 77.11 142.41
Operating Profit -4.87 -3.47 -25.18 -8.8 3.3
Other Income 1.26 1.03 1.92 2.11 9.54
Interest 12.4 0 0.27 0.57 2.63
Depreciation 0.16 0.13 0.84 1.32 4.63
Exceptional Items 0 0 0 0 0
Profit Before Tax -16.16 -2.57 -24.36 -8.57 5.58
Tax 0 0 0.51 0 0
Net Profit -16.16 -2.57 -24.87 -8.57 5.58
Adjusted EPS (Rs.) -833.14 -132.42 -1282.16 -38.25 0.47

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Equity and Liabilities
Share Capital 0.19 0.19 0.19 0.45 23.86
Total Reserves 185.01 185.01 395.41 517.03 1088.92
Borrowings 0 0 0 0 0
Other N/C liabilities 0.01 0.13 3.45 7.34 42.4
Current liabilities 3.34 6.17 16.17 23.6 32.28
Total Liabilities 188.55 191.51 415.23 548.42 1187.45
Assets
Net Block 0.26 0.15 7.17 22.68 85.02
Capital WIP 0 0 0.95 2.01 15.52
Intangible WIP 0 0 0 0 0
Investments 180.72 186.03 381.09 408.5 418.45
Loans & Advances 2.47 2.39 1.12 8.75 11.13
Other N/C Assets 0 0.03 0 0 0
Current Assets 5.11 2.93 24.9 106.49 657.34
Total Assets 188.55 191.51 415.23 548.42 1187.45
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Profit from operations -16.16 -2.57 -24.36 -8.57 5.58
Adjustment -0.79 0.32 31.25 8.22 0.65
Changes in Assets & Liabilities 1.54 1.26 -4.79 -6.17 -24.92
Tax Paid 1.93 0.06 0.79 0.28 -2.01
Operating Cash Flow -1.1 -0.93 2.89 -6.24 -20.71
Investing Cash Flow -1.55 -2.81 -196.64 -14.77 -633.66
Financing Cash Flow 6.65 0 203.96 96.94 568.63
Net Cash Flow 4.01 -3.74 10.21 75.94 -85.74

Corporate Actions

Investors Details

PARTICULARS Dec 2021% Mar 2022% Jun 2022%
Promoters 40.43 40.43 40.43
lone furrow invest... 28.88 14.44 14.44
agilemed investmen... 13.12 13.12 13.12
madhukar reddy gan... 12.87 12.87 12.87
PARTICULARS Dec 2021% Mar 2022% Jun 2022%
Investors 59.57 59.57 59.57
lavender rose inve... - 17.24 17.24
lavender rose inve... 17.24 - -
pi opportunities f... 14.11 14.11 13.98
sbi long term adva... - 8.90 -
sbi healthcare opp... 8.89 - -
sbi consumption op... - - 8.77
sbi life insurance... - - 1.53
pravesa holding pr... 1.52 1.52 1.52
sbi life insurance... 1.32 1.45 -
icici prudential l... 1.21 1.11 -
bhaskar reddy cher... 1.13 1.13 1.13
nippon life india ... 1.06 - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

X